🦊/People

Anja Koenig

Investor

Global Head of NVF at Novartis Venture Fund

Basel, CH

Find your path to Anja

418 people in our graph share verified history with Anja — schools, employers, funds. One of them is your warm intro.

Mike ZakunlockedAnja: together at Cornell (1995–2000)
×7Anja: together at Cornell
Anja: together at Sensirion
×2Anja: together at Mediar Therapeutics

Experience

  1. NovartisGlobal Head Novartis Venture Fundcurrent2017 — presentBasel, Basel, Switzerland
  2. NovartisManaging Director Novartis Venture Fund2007 — 2017
  3. NovartisStrategic Assistant to Chairman and CEO2006 — 2007Basel, Basel, Switzerland
  4. SensirionIndependent Board Director (Verwaltungsrat)current2021 — presentZürich Metropolitan Area
  5. InnosuisseDirector Board of Directorscurrent2025 — presentSwitzerland
  6. Mediar TherapeuticsBoard Director2023 — 2025Boston, Massachusetts, United States
  7. SNSF Swiss National Science FoundationMember of the Board of Trustees (Stiftungsrat and Stiftungsratsausschuss)2021 — 2024Berne, Switzerland
  8. Forendo Pharma LtdBoard Director2014 — 2021Turku, Southwest Finland, Finland
  9. ArctosBoard Director2020 — 2021Basel, Switzerland
  10. Ribon TherapeuticsBoard Director2019 — 2021Greater Boston
  11. ETH ZürichInvestment Committee Member2019 — 2021Zurich, Switzerland
  12. University of ZurichBoard Director of UZH Life Sciences Fund2017 — 2020
  13. BRIDGE Programm (SNSF-Innosuisse)Steering Committee Member and POC Jury2018 — 2019Bern Area, Switzerland
  14. Bicycle TherapeuticsBoard Director2009 — 2019Cambridge, United Kingdom
  15. ANAVEON AGBoard Director2018 — 2019Basel, Switzerland
  16. BaseLaunchJury member2016 — 2018Basel, Basel, Switzerland
  17. Cutiss AGBoard director2017 — 2018Zurich, Switzerland
  18. F2GBoard director2011 — 2018Manchester Area, United Kingdom
  19. Sosei HeptaresBoard Director2009 — 2015London, Greater London, United Kingdom
  20. Covagen AGBoard Director2007 — 2014Zurich, Switzerland
  21. Nabriva Therapeutics plcBoard Director2008 — 2013Vienna, Vienna, Austria
  22. MerLion Pharmaceuticals Pte LtdBoard director2007 — 2009Singapore

Skills & more

Board of DirectorsVenture Capital52Biotechnology23Life Sciences5Technology Transfer5Pharmaceutical Industry4Mergers & Acquisitions17M&A experience2Medical Devices7Strategy5Lifesciences5Start-ups5
+11 moreCorporate DevelopmentDue DiligenceCommercializationManagement ConsultingCross-functional Team LeadershipClinical DevelopmentStrategic PlanningDrug DevelopmentResearch and Development (R&D)Financial ModelingBiopharmaceuticals

From Anja's professional profile.

Deals · 1

Mediar TherapeuticsBoard seat

via Novartis Venture Fund · filed Oct 2024 · $85M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Investor

Bicycle TherapeuticsCovagenDiagnoplexF2GForendo PharmaNabriva TherapeuticsOxagenPharmAbcine

Sources: SEC Form D filings · curated public sources.

Colleagues at Novartis Venture Fund

Network5

Investors connected to Anja in public investor directories — a warm-intro map.

Frequently asked questions

Who is Anja Koenig?
Global Head of NVF at Novartis Venture Fund
Where does Anja Koenig work?
Anja Koenig is Global Head of NVF at Novartis Venture Fund.
What boards does Anja Koenig sit on?
Anja Koenig holds tracked board seats at Mediar Therapeutics.
What companies has Anja Koenig invested in?
Investments tracked here include Bicycle Therapeutics, Covagen, Diagnoplex, F2G, Forendo Pharma, Nabriva Therapeutics, Oxagen, PharmAbcine.
Where did Anja Koenig go to school?
Anja Koenig studied at Cornell University (PhD, Physics); Ludwig-Maximilians-Universität München (Masters (Diplom), Physics); University of Oxford (Physics).

Same school

Shared employers